Carly Pointon
Papers
1
Total Citations
58
H-Index
1
About
Carly Pointon is a leading figure in high-throughput screening and assay development, with a specialized focus on advancing the precision and reliability of cell-based drug discovery. Her most-cited work, "Achieving Accurate Compound Concentration in Cell-Based Screening: Validation of Acoustic Droplet Ejection Technology" (2009, 58 citations), represents a pivotal contribution to the field. In this study, Pointon rigorously validated acoustic droplet ejection (ADE) as a transformative method for delivering nanoliter volumes of compounds directly into assay plates, eliminating the variability and inaccuracies associated with traditional tip-based liquid handling. This work directly addressed a critical bottleneck in early-stage drug discovery—ensuring that compound concentrations in cell-based screens are both accurate and reproducible, thereby reducing false positives and false negatives. By demonstrating that ADE technology could achieve high precision without compromising cell viability or assay performance, Pointon provided the pharmaceutical industry with a robust, scalable solution for compound management. Her validation study has become a foundational reference for laboratories implementing acoustic dispensing, influencing best practices in screening operations. Through this work, Pointon has significantly enhanced the efficiency and data quality of preclinical drug development, making her a respected authority in assay miniaturization and automation.
Research Focus
Key Achievements
Top Papers
- 1